Document Classification

Section Type: RESULTS

Text: At week 24, adjusted mean (SE) changes from baseline in HbA1c with empagliflozin 25 mg/linagliptin 5 mg, empagliflozin 10 mg/linagliptin 5 mg, empagliflozin 25 mg, empagliflozin 10 mg, and linagliptin 5 mg were -1. 08 (0. 06) % (-11. 8 [0. 7] mmol/mol), -1. 24 (0. 06) % (-13. 6 [0. 7] mmol/mol), -0. 95 (0. 06) % (-10. 4 [0. 7] mmol/mol), -0. 83 (0. 06) % (-9. 1 [0. 7] mmol/mol), and -0. 67 (0. 06) % (-7. 3 [0. 7] mmol/mol), respectively.